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MicroRNAs Modulate Schwann Cell Response to Nerve
Injury by Reinforcing Transcriptional Silencing of
Dedifferentiation-Related Genes
Andreu Viader,1* Li-Wei Chang,2* Timothy Fahrner,1 Rakesh Nagarajan,2 and Jeffrey Milbrandt1,3
1Department of Genetics, 2Department of Pathology and Immunology, 3Hope Center for Neurological Diseases, Washington University School of Medicine,
St. Louis, Missouri 63110
In the peripheral nervous system, Schwann cells (SCs) surrounding damaged axons undergo an injury response that is driven by an
intricate transcriptional programand is critical for nerve regeneration. To examinewhether these injury-induced changes in SCs are also
regulated posttranscriptionally bymiRNAs, we performedmiRNA expression profiling ofmouse sciatic nerve distal segment after crush
injury. We also characterized the SC injury response in mice containing SCs with disrupted miRNA processing due to loss of Dicer. We
identified 87 miRNAs that were expressed in mouse adult peripheral nerve, 48 of which were dynamically regulated after nerve injury.
Most of these injury-regulated SC miRNAs were computationally predicted to inhibit drivers of SC dedifferentiation/proliferation and
thereby re-enforce the transcriptional program driving SC remyelination. SCs deficient in miRNAs manifested a delay in the transition
between the distinct differentiation states required to support peripheral nerve regeneration. Among the miRNAs expressed in adult
mouse SCs, miR-34a and miR-140 were identified as functional regulators of SC dedifferentiation/proliferation and remyelination,
respectively.We found thatmiR-34a interacted with positive regulators of dedifferentiation and proliferation such as Notch1 and Ccnd1
to control cell cycle dynamics in SCs. miR-140 targeted the transcription factor Egr2, a master regulator of myelination, and modulated
myelination inDRG/SC cocultures. Together, these results demonstrate that SCmiRNAs are importantmodulators of the SC regenerative
response after nerve damage.
Introduction
Neuronal regeneration in adult vertebrates is largely limited to
the peripheral nervous system (PNS). Unlike neurons in the
CNS, PNS neurons are capable of long-distance axonal regener-
ation. Central to the differential plasticity of peripheral neurons
are Schwann cells (SCs), the glial cells of the PNS. SCs have the
striking ability to dedifferentiate and revert back to an immature-
like state following axonal loss (Jessen andMirsky, 2008). After a
transient phase of proliferation, dedifferentiated SCs help sup-
port axonal regeneration by clearing myelin debris, forming tu-
bular structures known as bands of Bungner, and upregulating
the synthesis of a number of neurotrophic factors. As peripheral
axons regenerate, SCs redifferentiate to formmatureRemakbun-
dles or new myelin sheaths, helping to restore, in this way, pe-
ripheral nerve function (Geuna et al., 2009). Greater insight into
this highly orchestrated process of SC-mediated support of ax-
onal regeneration could help improve the treatment of peripheral
and central neurodegenerative diseases characterized by ax-
onopathy, including diabetic neuropathy and amyotrophic lat-
eral sclerosis (Coleman, 2005).
MicroRNAs (miRNAs) are small (22 nt) noncoding RNAs
capable of posttranscriptionally regulating protein expression.
miRNAs have emerged as ubiquitous regulators of developmen-
tal timing and cellular differentiation (Flynt and Lai, 2008). The
central role of miRNAs in cell fate determination suggests that
they could modulate the transcriptional program responsible for
the dedifferentiation and redifferentiation of SCs following nerve
injury (Jessen and Mirsky, 2008). This idea is supported by ze-
brafish studies implicating miRNAs in the regulation of tissue
regeneration (Thatcher et al., 2008; Yin et al., 2008; Ramachan-
dran et al., 2010).Moreover,miRNAs are essential for the normal
development of SCs, as miRNA-deficient SCs are unable to dif-
ferentiate past an immature state (Bremer et al., 2010; Pereira et
al., 2010; Yun et al., 2010). The behavior, identity, and potential
role of miRNAs in the regenerative response of adult SCs after
nerve injury, however, remain unexplored.
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In this study, we examined the dynamics of miRNA expres-
sion in mouse sciatic nerve following crush-induced axonal loss.
We identified 87miRNAs consistently expressed in adult periph-
eral nerve. Most of these SC miRNAs were computationally pre-
dicted to inhibit drivers of SC dedifferentiation/proliferation and
their expression was dynamically regulated after injury to po-
tentially re-enforce the transcriptional program driving the SC
regenerative response. Accordingly, miRNA-deficient SCs had
delayed transitions between the distinct differentiation states
involved in the SC injury response. Among the miRNAs con-
sistently expressed in SCs, miR-34a and miR-140 were char-
acterized as functional regulators of two distinct processes
performed by SCs following peripheral nerve damage: prolifera-
tion and myelination. Together, our results demonstrate that
miRNAs are important modulators of the SC regenerative re-
sponse after nerve damage.
Materials andMethods
Animals andmatings.All animal experiments were performed in compli-
ance with institutional animal protocols. For all nerve-lesion studies,
except those involving mice lacking Dicer specifically in SCs (Dicer-
SCKOs), C57BL6 mice of either gender were used. Dicer-SCKO mice
were generated by crossing Dicer loxP/loxP mice (Cobb et al., 2005) to
PLP-CreERT
/ mice (Doerflinger et al., 2003). Compound heterozy-
gotes (PLP-CreERT
/, Dicer/loxP) were then backcrossed to homozy-
gous Dicer loxP/loxP to generate PLP-CreERT
/, Dicer loxP/loxP mice.
One-month-old PLP-CreERT
/, Dicer loxP/loxP mice of either gender
were injected daily with 100g/g tamoxifen (10mg/ml stock dissolved in
a 10:1 peanut oil/ethanol mixture) for a total of 10 d (with a 2 d break
after day 5) to generate Dicer-SCKOs. Control (Ctrl) mice were injected
in the same way with vehicle alone (10:1 peanut oil/ethanol mixture).
PLP-CreERT
/ were also crossed to Rosa26-YFP/ mice to generate
PLP-CreERT
/, Rosa26-YFP/mice, which were treated with tamox-
ifen in an analogous manner.
Surgical procedures. For lesion studies, adult mice (2–3 months of age)
were anesthetized by intraperitoneal injection of Avertin. The sciatic
nerve was exposed at the hip and either crushed using No. 5 jeweler’s
forceps for 30 s or transected using small scissors. In the case of transec-
tion, the distal stump was deflected onto an adjacent muscle to prevent
regeneration.When necessary, the site of injury wasmarked with a single
10-0 nylon epineural suture. Nerve lesions were produced on the right
side and the intact contralateral nerve served as the uninjured control. At
the appropriate time points, nerves were harvested and processed for
histology or immediately frozen in liquid nitrogen for subsequent extrac-
tion of RNA.
RNA preparation and quantitative real-time PCR.Total RNAwas isolated
after homogenization (for sciatic nerves) or lysis (for cultured SCs) inQiazol
lysis reagent (Qiagen) using a miRNeasy Minikit (Qiagen) according to the
manufacturer’s protocol. RNA concentration was quantified using an ND-
1000 spectrophotometer (Nanodrop Technologies). mRNA was reverse
transcribed from 100 ng of total RNA using qScript cDNA SuperMix
(Quanta Biosciences) while miRNAwas reverse transcribed from 100 ng of
total RNA using NCode Vilo miRNA cDNA synthesis kit (Invitrogen).
mRNA qRT-PCR was performed using a SYBR green-based detection sys-
tem on a 7900 HT Sequence Detector instrument (Applied Biosystems), as
described previously (Nagarajan et al., 2001). GAPDH expression was used
to normalize samples and obtain relative expression values thatwere used to
calculate percentage changes. miRNA qRT-PCR was performed in an anal-
ogous manner, but cycling conditions were adapted as per NCode Vilo
miRNA qRT-PCR kit (Invitrogen) recommendations. U6 snRNAwas used
for normalization. The sequences of the qRT-PCR primers used are as fol-
lows (5-3): Dicer: forward, AATTGGCTTCCTCCTGGTTAT; reverse,
GTCAGGTCCTCCTCCTCCTC; mir-34a: forward, GGCAGTGTCT-
TAGCTGGTTGT;mir-26a: forward,GATTTCAAGTAATCCAGGATAG-
GCT; mir-140: CAGTGGTTTTACCC TATGGTAG; all miRs reverse,
NCode Vilo Universal Primer; Egr-2: forward, CATGGGCAAATTCTC-
CATTGA; reverse, TTGCAAGATGCCCGCAC; MPZ: forward, CCCTG-
GCCATTGTGGTTTAC; reverse, CCATTCACTGGACCAGAAGGAG.
MBP: forward, CCAGTAGTCCATTTCTTCAAGAACATT; reverse, AG-
CTAAATCTGCTGAGGGACAGG. Ccnd1: forward, GCGTACCCTGA-
CACCAATCT; reverse, GAACCGGTCCAGGTAGTT CA; Notch1:
forward, TGACCTGCTCACTCTCACAGA GTAC; reverse, CGACA-
GATGTATGAAGACTCAAAGG.
Microarray and computational analysis. SCmicroarray gene expression
profiling experiments were performed in previous studies using Af-
fymetrix MU74v2 chips (Nagarajan et al., 2002). Expression data were
processed and normalized using Affymetrix MAS5 algorithm. An SC-
expressed gene was defined as one that was called present in at least one
time point during SC regeneration. k-Means clustering was used to clus-
ter genes based on their expression profiles; gene clusters that had an
expression pattern similar to the previously identified myelination or
proliferation profile (Nagarajan et al., 2002) based on the Pearson corre-
lation coefficient were identified and merged. The average expression
profile, i.e., the centroid, was calculated as the final myelination or pro-
liferation profile.
For miRNA expression profiling, total RNA samples were prepared by
isolating and pooling RNA from at least three different mice at the ap-
propriate times after nerve crush. Replicates were prepared entirely in-
dependently from two separate pools of at least three animals each. Two
replicates were used for hybridization onto qNPA miRNA microarrays
(HTG Molecular) according to the manufacturer’s protocol, and mi-
croarray images were obtained and background subtracted as per the
manufacturer’s recommendations. Scanned miRNA microarray expres-
sion data were first processed using the software provided by the manu-
facturer. Thismicroarray platform includes duplicate probe sets for 1046
miRNAs. miRNA expression data were further filtered using the follow-
ing criteria: (1) the average of the expression of controlmiRNAprobe sets
on the array was used as a cutoff to remove miRNAs that have low or no
expression, and (2) miRNAs for which the expression of one duplicate
probe set at all time points were significantly higher than that of the other
duplicate probe set were also removed for further analysis, based on a
Mann–WhitneyU test. Expression data were then z-score normalized for
each miRNA and the average expression of the two duplicate probe sets
was calculated at each time point. ThesemiRNA expression profiles were
compared with the previously identified myelination or proliferation
profiles in the following target bias analysis.
TargetScanS, PicTar, and miRanda algorithms were used to predict
potential miRNA regulatory targets. miRNA targets predicted by these
programs were downloaded from the program websites. miRNA target
bias analysis was performed as follows: for each miRNA, SC-expressed
genes that had an miRNA seed sequence match in the 3UTR were iden-
tified using TargetScanS. The Pearson’s correlation coefficient of gene
and miRNA expression profiles was calculated for each target and non-
target. The Mann–Whitney test p value was calculated to test whether
miRNA target genes tend to have higher expression correlations with
miRNA than nontarget genes, i.e., a positive target bias.
Immunohistochemistry. The following primary and secondary anti-
bodies were used: chicken anti-GFP (1:1000; Aves), rabbit anti-III
tubulin (1:1000; Covance), rabbit anti-phosphohistone 3 (1:200; Mil-
lipore), rat anti-MBP (1:100; Millipore), anti-rabbit Cy3 (1:500; Jack-
son ImmunoResearch Laboratories), anti-rat Cy3 (1:500; Jackson
ImmunoResearch Laboratories), and anti-chicken Alexa 488 (1:500;
Jackson ImmunoResearch Laboratories).
For immunohistochemical analysis of sciatic nerves, nerves were dis-
sected, immersion fixed in 4% paraformaldehyde for 2 h, rinsed with
PBS, and cryoprotected in 30% sucrose. Sciatic nerves were then embed-
ded in Tissue-Tek OCT compound (Sakura Finetek) and sectioned at 6
m. All frozen sections were immunostained by postfixing in ice-cold
acetone at20°C for 10 min and blocking in 5% fish skin gelatin in PBS
0.2% Triton for 1 h at room temperature. Sections were then incubated
with primary antibody diluted in blocking buffer overnight at 4°C. Sec-
ondary antibody incubation was performed at room temperature for 1 h
also in blocking buffer. After all stainings, sections were mounted with
VectashieldmountingmediumwithDAPI (Vector Laboratories) formi-
croscopic visualization. Images were captured using an upright micro-
scope equipped for epifluorescence microscopy (Nikon 80i, and
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CoolSnapES camera; Photometrics) and were processed using Meta-
Morph, ImageJ, and Gimp software using global adjustments for bright-
ness and contrast. All cell number quantifications were performed by
counting the cells of interest in four randomly selected regions in longi-
tudinal nerve sections from each animal assessed (at least three mice per
genotype at each time point) at a 20magnification. The area covered by
MBP immunostaining was determined using ImageJ after automated
background adjustment and binarization (Sasaki et al., 2009) from four
randomly selected fields at a 20 magnification in longitudinal nerve
sections. MBP area was normalized to total nerve area; results represent
the average of at least three mice per genotype.
Nerve light and electron microscopy and morphometry. Sciatic nerve
segments from Dicer-SCKO or Ctrl mice were dissected at the appropri-
ate times after injury and placed in 3% glutaraldehyde overnight. The
isolated nerve segments were 15 mm in length and, in the case of
crush-injured nerves, included the distal regenerated stump. After wash-
ing with phosphate buffer, nerves were postfixed in 1% osmium tetraox-
ide in phosphate buffer overnight at 4°C. Specimens were then
dehydrated in graded alcohols and embedded in 100% epoxy (Araldite
502). One-micrometer-thick plastic embedded sections were prepared
and stained with toluidene blue for light microscopy. For electron mi-
croscopy, thin sections were prepared, stained with uranyl acetate and
lead citrate, and photographed with a JEOL 1200 electron microscope.
All nerves underwent qualitative assessment of neural architecture fol-
lowed by detailed histomorphometric analysis performed in a blinded
fashion, as previously described (Hunter et al., 2007), using at least three
mice per genotype at each time point. For injured nerves, histomorpho-
metric analysis was performed 5mm distal to the crush site. Total regen-
erated axon counts were determined by counting both remyelinated and
non-remyelinated axons in Ctrl andDicer-SCKOnerves 14 d after injury
from electron micrographs taken at 5000magnification.
Plasmids.miRNAs were obtained by PCR amplifying individual miRNA
precursors from genomic DNA. The resulting fragments were cloned be-
tween theBamHI andNheI sites in themiRNASelect pEP-MIRCloning and
Expression Vector (Cell Biolabs) using the InFusion HD cloning system
(Clonetech) according to the manufacturer’s recommendations. Pre-
miRNAs included themiRNA stem loop and100 nt of flanking sequence
on either side and were amplified using the following primers: pre-mir-
34a: forward, TAGTTCTCGAGGATCCCCAGCTGAATCCCGACTA GT;
reverse, AAAAGCTCGAGCTAGCTCTCTTAGCCAGAAGTGCTC;
pre-mir-140: forward,TAGTTCTCGAGGATCCGCCTCTGACCCTGCT-
TGCTGGTGGTGTA; reverse, AAAAGCTCGAGCTAGC CCAACA-
CCCACCCAATAGACGCCT. pEP-mirNullVector (Cell Biolabs)was used
as Ctrl.
A lentiviral miRNA expression vector was made by PCR amplifying the
pEP-MIR expression cassette (promoter, miR processing portion, and
mCherry reporter: forward, AGATCCAGTTTGGTTAATTAAGTGAGG
CTCCGGTGCCCGTCA; reverse, TAGAG TCGCGGCCGCTTTACTTG-
TACAGCTCGTCCATGCCGCCGGTGGA) and subcloning it between the
PacI and BsrgI sites of an FCIV lentiviral vector (Araki et al., 2004) using the
InFusion HD cloning system (Clonetech) according to the manufacturer’s
recommendations. For luciferase assays, the 3UTR regions of Egr2, Notch1,
and Ccnd1 were PCR amplified from genomic DNA using the following
primers: Ccnd1 3UTR: forward, AAAGCTGCGCACTAGTGGG CCAC-
CGGGCAGGCGGGAGCCA; reverse, ATCCTTTATTAAGCTTTGAGAT-
TTTACCAATTT TATTT; Notch1 3UTR: forward, AAAGCTGCGCAC-
TAGTACAGAGATGTGGGATGCAGGACC; reverse, ATCCTTTATTA-
AGCTTGTTTAGCAAAATGTGGACAACCA; Egr2 3UTR: forward,
AAAGCT GCGCACTAGTGATGAAGCTCTGGCTGACACACCA; re-
verse, ATCCTTTATTAAGCTTACCA TAGTCAATAAGCCATCCAT.
DNA fragments were cloned downstreamof the luciferase gene between the
HindIII and SpeI sites in the pMIR-REPORTmiRNA Expression Reporter
Vector (Ambion). The 3UTR of Egr2 lacking themiR-140 landing pad was







AGAATAGATTGTTTCTCTCT. pRL-CMV Renilla Luciferase Reporter
Vector (Promega) was used as a transfection control.
Lentivirus production. Lentiviruses expressing miR-34a, miR-140, or a
Ctrl miRNA were produced in HEK293T cells as previously described
(Sasaki et al., 2006).
Luciferase assays. HEK293T cells were seeded at a density of 50,000
cells/well in 24-well plates in DMEM media (Invitrogen) supplemented
with 10% fetal bovine serum (FBS), 2 mM L-glutamine. Cell were trans-
fected 24 h later, with either a pEP-MIR vector expressing a pre-miRNA
or with the pEP-mir null control and pMIR-REPORT luciferase reporter
vector containing the appropriate 3UTR linked to luciferase. pRL-CMV
renilla luciferase reporter vector (Promega) was used as a transfection
control. A total of 200 ng of plasmid DNA per well were transfected at a
ratio of 50:1:0.5 (miRNA:luciferase reporter:transfection Ctrl). Cells
were harvested 48 h posttransfection and assayed using a dual-luciferase
reporter assay system (Promega) according to the manufacturer’s
protocol.
Primary SC cultures and lentiviral infection. Primary rat SCs were cul-
tured from postnatal days 1–3 rat pups sciatic nerves as previously de-
scribed (Nagarajan et al., 2001). Established SC cultures were then
transduced at an early passage (passage 3) with a lentiviral vector ex-
pressingmiR-34a, miR-140, or a Ctrl miRNA. Efficiency of infection was
confirmed by visualization of expression of mCherry fluorescent re-
porter in the pEP-MIR cassette in almost 100% cells.
SC in vitro proliferation, differentiation, or myelination assays. For SC in
vitrodifferentiationassays,Ctrl ormiR-140overexpressingSCswere initially
seededonto collagen-coated24-well plates (75,000 cells/well) in 10%FBS-
DMEMmedia; 24 h later, cells were switched to 1% FBS-DMEMmedia for
2d. SCswere then induced todifferentiateby adding1%FBS-DMEMmedia
containing 250 M 8-(4-chlorophenylthio)adenosine-3,5 cyclic mono-
phosphate (cpt-cAMP; Biolog). RNA was isolated 72 h later. Reported re-
sults are from duplicate wells from two independent assays. For SC
proliferation and in vitromyelination assays, dorsal root ganglion neurons
weredissected fromE14 rat embryos, dissociated, and seededontoMatrigel-
coated (BD Biosciences) four-well plates in Neurobasal media (Invitrogen)
containing 2%B27 (Invitrogen) and50ng/mlNGF.Gliawere eliminatedby
addition of 20 M 5-fluoro-2-deoxyuridine (Sigma) and 20 M uridine
(Sigma) to themedia for 4 d. Seven days after seeding, DRGs were switched
toF-12/DMEMmedia supplementedwith 15%FBS, 2mML-glutamine, and
50ng/mlNGF, andCtrl ormiR-overexpressing SCswere added to eachwell.
To examine SC proliferation, 25,000 Ctrl or miR-34a-overexpressing SCs
per well were plated onto DRG neurons and growth curves were generated
by monitoring changes in cell number over 5 d. mCherry-positive cells ex-
pressingmiR-34awere visualized at 20magnification andquantified from
five randomly selected fields. Results are averages from triplicate wells from
two independent assays. For in vitromyelination assays, 50,000 Ctrl ofmiR-
140-overexpressingSCsperwellwereplatedontoDRGneuronsandallowed
to proliferate and ensheath axons for 7 d. At this point, myelination was
induced by adding 50g/ml ascorbic acid.Myelinationwas allowed to pro-
ceed for 14dandmyelinated segmentswere visualized throughMBP immu-
nostaining at 20magnification as previously described (Ryu et al., 2008).
The number ofmyelinated segmentswas quantified by averaging five differ-
ent fields from triplicate wells in three independent assays.
Western blotting. Ctrl and miRNA-overexpressing SCs were lysed in
200l of buffer containing 150mM sodium chloride, 50 mMHEPES, 1%
NP-40, 1 mM EDTA, 1 mM sodium fluoride, 1 mM sodium orthovanod-
ate, and complete protease inhibitor mixture (Roche Applied Science).
Lysates were clarified by centrifugation at 14,000 rpm for 10 min and
quantified using the MicroBCAProtein assay kit (Pierce). For Western
blotting, the proteins were separated by SDS-PAGE and transferred to a
PVDF membrane (Millipore). Membranes were blocked in 5% milk in
0.1% TBS-Tween and incubated overnight with the appropriate primary
antibody. Following incubationwith secondary antibodies conjugated to
HRP (GE Healthcare), membranes were developed with SuperSignal
West Dura substrate (Pierce). The primary antibodies used were mouse
anti-Ccnd1 (1:1000; Cell Signaling Technology), anti-Notch1 (1:1000;
Cell Signaling Technology), and rabbit anti-Egr2 (1:1000; Covance). The
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secondary antibodies used were anti-mouse and anti-rabbit HRP (1:
5000; Jackson ImmunoResearch Laboratories).
Statistical analysis. All values are expressed as mean  SEM. If not
stated otherwise, p values were determined by unpaired, two-tailed Stu-
dent’s t test. All statistical analyses were performed usingMicrosoft Excel
2007.
Results
Dynamics of SCmiRNA expression after injury are consistent
with a modulatory role in the SC regenerative response
To study the potential regulatory role of miRNAs in the SC re-
generative response after peripheral nerve injury, we performed
miRNA microarray expression profiling of mouse sciatic nerves
after crush-induced axonal degeneration. In previous work ex-
amining mRNA expression profiles during the SC injury re-
sponse (Araki et al., 2001; Nagarajan et al., 2002; Bosse et al.,
2006), we and others found that expression of regulators of SC
dedifferentiation/proliferation andmyelination peaks 4 (C4) and
14 (C14) d after nerve crush, respectively. In the present study, we
therefore profiled miRNA expression in the distal stump of in-
jured nerves at C4 and C14, as miRNAs that are differentially
expressed at these two time points are likely to be involved in the
regulation of the SC regenerative response.
We identified 87 miRNAs that were reproducibly detected in
the adult peripheral nerve (Fig. 1). Given that SCs constitute
80% of the cells in mouse sciatic nerves (King, 2005), the de-
tected miRNAs primarily represent the microRNAome of these
glia. Indeed, over one-third of the miRNAs detected by our mi-
croarray analysis were previously found to be expressed in cul-
tured isolated SCs (Verrier et al., 2009). Moreover, several of the
most highly expressed miRNAs identified, including let-7f, miR-
138, miR-145, and miR-16, have been previously related to the
postnatal development of SCs (Bremer et al., 2010; Verrier et al.,
2010; Yun et al., 2010). Remarkably, the expression of over half of
the detected miRNAs was upregulated or downregulated in the
distal nerve segment following crush injury (48 of 87; C4 vs Ctrl,
p  0.05), suggesting that miRNAs may indeed play a role in
modulating the processes of SC dedifferentiation and remyelina-
tion after injury.
Genes involved in the dedifferentiation/proliferation and re-
myelination of SCs following crush-induced axonal degeneration
are dynamically regulated and have reciprocal patterns of expres-
sion (Nagarajan et al., 2002).We reasoned thatmiRNAs involved
in the SC injury response would be dynamically regulated in a
manner similar to genes known to be important for the regula-
tion of this process. We applied k-means clustering to our previ-
ous SC mRNA expression profiling datasets (see Materials and
Methods, above) and identified gene clusters containing known
regulators of SC dedifferentiation/proliferation (proliferation
profile) or differentiation/myelination (myelination profile) af-
ter injury (Fig. 2a) (Nagarajan et al., 2002). Of the 48 miRNAs
differentially regulated following nerve crush injury, 31 were ex-
pressed in a pattern that was highly correlated with either the
myelination or proliferation profile (with a Pearson’s correlation
coefficient 0.8). Interestingly, 21 of these miRNAs were regu-
lated similarly to genes in the myelination cluster: their expres-
sion was inhibited immediately after injury and increased as
remyelination ensued (Fig. 2a). The expression of a significant
Figure 1. Expression profiles of 87 miRNAs expressed in SC. z-Score-normalized miRNA ex-
pression levels 4d (C4) and14d (C14) after nerve crush injury aswell as inuninjurednerves (Ctrl)
4
are shown in a heat map. Red indicates higher expression than the average across all samples;
green indicates lower expression. mmu refers to the standard abbreviation used to designate
miRNAs of mouse origin.
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portion of SC miRNAs, therefore, is dynamically regulated after
crush injury in a manner consistent with them playing a critical
role in modulating the SC regenerative response.
Target bias analysis suggests that SCmiRNAsmodulate the
injury response by repressing positive regulators of SC
dedifferentiation/proliferation
miRNAs often act in concert with transcriptional control to reg-
ulate target gene expression more efficiently (Hornstein and
Shomron, 2006). For this reason, biologically relevant miRNAs
tend to be either coexpressed (positive target bias) or negatively
correlated (negative target bias) with their predicted targets to
either fine-tune or inhibit their activity, respectively (Tsang et al.,
2007). We hypothesized that miRNAs could modulate the SC
injury response in a similarmanner by cooperating with the tran-
scriptional regulatory program that controls this process. An
miRNA whose expression profile is correlated with that of
myelination-associated genes (Fig. 2a) could thus reinforce
the transcriptional program driving remyelination by inhibit-
ing positive regulators of SC dedifferentiation/proliferation
(demonstrating a negative target bias) or by modulating
myelination-associated genes (demonstrating a positive target
bias). Conversely, anmiRNAwhose expression is correlated with
that of proliferation/dedifferentiation-associated genes could co-
ordinate with the transcriptional regulatory program by inhibit-
ing drivers ofmyelination (negative target bias) or by fine-tuning
proliferation-related genes (positive target bias). To begin to ad-
dress the biological function of SC miRNAs in modulating the
injury response, we therefore studied their target bias as well as
examined their correlation with the proliferation and myelina-
tion expression profiles.
We first used the TargetScanS algorithm (Grimson et al.,
2007) to identify SC-expressed genes that were predicted targets
of the 87 miRNAs we detected in SCs. We found that 59 of the 87
miRNAs detected by our microarray analysis had predicted tar-
gets among the 8000 transcripts detected in our previous SC
Figure 2. Target bias analysis suggests that SCmiRNAsmodulate the injury response by repressing positive regulators of SC dedifferentiation/proliferation. a, mRNA expression profiles of gene
clusters containing known regulators of SC dedifferentiation/proliferation (the proliferation profile) or differentiation/myelination (themyelination profile) after injury.b, Graph plotting the target
bias for each miRNA in subset 1 (measured by a Mann–Whitney z-score) against the correlation of its expression with the myelination or proliferation profile (measured by	CC, the difference in
correlation coefficients with the proliferation profile and themyelination profile). Biological functions ofmiRNAs in regulating the SC injury responsemay be inferred from their correlationwith the
proliferation ormyelination gene clusters and by their positive or negative target bias. Themajority of SCmiRNAs cluster in the top left quadrant of the graph (negative target bias, correlationwith
the myelination profile), suggesting that SC miRNAs are likely to modulate the injury response primarily through their inhibition of positive regulators of SC dedifferentiation/proliferation. Dotted
and dashed lines represent statistical significance cutoffs. miRNAs differentially regulated after injury (C4 vs Ctrl p 0.05), with a statistically significant target bias and a high correlation with the
myelination or proliferation clusters (	CC 1.6), are represented by triangles. Empty circles represent miRNAs that met statistical significance cutoffs for target bias and high correlation with the
myelination or proliferation clusters, but were not differentially regulated after injury. c, miRNAs likely to be direct regulators of the SC injury response (triangles in b) based on their differential
regulation after injury, significant target bias, and a high correlation with the myelination or proliferation clusters. d, Predicted targets for miRNAs in c are enriched for genes involved in cellular
processes that are normally inhibited in adult or differentiating SCs but are active in immature or proliferating SCs.
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mRNA expression profiling datasets (Nagarajan et al., 2002; our
unpublished observations). TargetScanS is a relatively stringent
miRNA target prediction algorithm, which requires an exact
match between themiRNA seed sequence and any predicted sites.
The 59 miRNAs we identified (subset 1) therefore represent a
high-confidence set of modulators of the SC injury response and
were further examined in our functional analysis.
We then used a Mann–Whitney U test to determine whether
the expression of eachmiRNA in subset 1 had a higher positive or
negative correlation with the expression of its predicted targets
than with that of predicted nontarget genes (indicative of a target
bias; see Materials and Methods, above). We found that 25 miR-
NAs in subset 1 had a significant target bias. Remarkably, 23 of
these 25 miRNAs had a negative target bias, meaning that when
the expression of a given miRNA was high, the mRNA level of its
putative targets tended to be low and vice versa. This prevalence
of a negative target bias is in agreement with previous studies
(Farh et al., 2005; Lau et al., 2008) and suggests that the majority
of SC miRNAs reinforce rather than fine-tune the concurrent
transcriptional regulatory processes (Tsang et al., 2007).
Finally, the extent of target bias for each miRNA in subset 1
(measured by aMann–Whitney z-score; seeMaterials andMeth-
ods, above) was plotted against the correlation of its expression
with the myelination or proliferation profile (measured by 	CC,
the difference in correlation coefficients with the proliferation
profile and the myelination profile). Interestingly, when plotted
in this manner, the majority of SC miRNAs clustered in the top
left quadrant of the graph, indicative of a negative target bias and
an expression pattern that correlated with that of genes in the
myelination cluster (Fig. 2b). Only six miRNAs had a negative
target bias and a high correlation with the expression pattern of
genes in the proliferation cluster. Similarly, very few miRNAs
showed a positive target bias (Fig. 2b). Importantly, these results
suggest that SC miRNAs are likely to modulate the injury re-
sponse primarily through their inhibition of positive regulators
of SC dedifferentiation/proliferation.
To further validate this conclusion, we performed gene ontol-
ogy enrichment analysis for the putative targets of miRNAs that
were as follows: (1) differentially regulated after injury (C4 vs
Ctrl, p 0.05), (2) demonstrated a statistically significant target
bias, and (3) had a high correlation with the myelination or pro-
liferation clusters (	CC  1.6). We reasoned that miRNAs that
met these three criteria were more likely to be direct regulators of
the SC injury response. Using these rigorous criteria, sixmiRNAs
were identified. Interestingly, these miRNAs all had a negative
target bias and an expression pattern that correlated with the
myelination profile (Fig. 2c). Gene ontology enrichment analysis
showed that the predicted targets of thesemiRNAswere enriched
for genes involved in cellular processes that are normally more
active in immature or proliferating SCs. These processes included
cell cycle regulation, cell migration, and regulation of transcrip-
tion or chromatin organization (Fig. 2d), and genes such as SC
mitogens (e.g., fibroblast growth factor), oncogenes (e.g., Kras),
or cyclins (e.g., cyclin E2). These results indicate that SCmiRNAs
regulate the injury response primarily by inhibiting positive reg-
ulators of SC dedifferentiation/proliferation, and reinforce the
transcriptional program that keeps these dedifferentiation/pro-
liferation genes quiescent in mature or differentiating SCs. This
reinforcement likely facilitates rapid and robust transitions be-
tween the distinct differentiation states involved in the SC injury
response (Farh et al., 2005; Stark et al., 2005).
SCs with disrupted miRNA processing show delays in cycling
between differentiation states after peripheral nerve injury
The results described above suggest thatmiRNAswork in concert
with transcriptional controls to ensure the correct extent and
timing of the SC dedifferentiation and subsequent remyelination
following nerve injury. To more directly examine this idea, we
performed nerve lesion studies onmice in which mature miRNA
synthesis was disrupted in SCs through the targeted deletion of
Dicer1¸ a gene encoding an essential enzyme in miRNA biosyn-
thesis (Bartel and Chen, 2004). Mice harboring loxP-flanked Di-
cer1 alleles (Cobb et al., 2005) were crossed to mice expressing a
tamoxifen-inducible form of Cre-recombinase in bothmyelinat-
ing and nonmyelinating SCs under the control of the proteolipid
protein promoter (PLP-CreERT) (Doerflinger et al., 2003). The
resulting PLP-CreERT:Dicer fl/fl mice were aged to 1 month and
then injected daily with either 100 g/g tamoxifen (Dicer-
SCKOs) or vehicle (Ctrl) for 10 consecutive days (see Materials
andMethods, above). Eight weeks after exposure to tamoxifen, a
majority of SC nuclei (82% 5.1%, identified morphologically)
in PLP-CreERT mice carrying a copy of a Cre-inducible Rosa26-
YFP reporter exhibited YFP fluorescence (Fig. 3a). Accordingly,
DicermRNA levels aswell as the basal levels of a number of highly
expressed miRNAs were significantly reduced in the sciatic
nerves of Dicer-SCKO versus Ctrl mice (Fig. 3b and data not
shown). However, at 8 weeks and for as long as 14 weeks after
tamoxifen treatment, nerves from Dicer-SCKO mice showed no
apparent pathology and were indistinguishable from Ctrl nerves,
indicating that disruption of miRNA processing in SCs after pe-
ripheral nervemyelinationwas fully completedwaswell tolerated
(Fig. 3g,h and data not shown).
To determine whether miRNA deficiency led to deficits in the
SC injury response and remyelination, sciatic nerves of Dicer-
SCKO and Ctrl littermates were crushed 8 weeks after tamoxifen
administration. We first examined the response of SCs to axonal
degeneration by assessing changes in SCproliferation and in their
ability to break down existing myelin (Geuna et al., 2009). The
rate of myelin loss, a measure of SC dedifferentiation, was similar
betweenDicer-SCKOandCtrlmice, with no differences observed
in the amount of myelin debris (Fig. 3c) or of MBP immunoflu-
orescence in the nerves after injury (data not shown). Similarly,
immunostaining of the nerve distal stump 4 d after injury using
an antibody against the proliferation marker phosphohistone 3
(PH3) showed that, following axonal loss, miRNA-deficient SCs
were able to reenter the cell cycle to the same extent as Ctrl SCs
(percentage of PH3-positive cells: Ctrl 
 12.37  0.47; Dicer-
SCKO 
 13.12  0.69; Fig. 3d,e). Depletion of miRNAs, there-
fore, did not interfere with the ability of SCs to dedifferentiate
and proliferate after injury.
We next studied the late phase of the SC-injury response, during
which these glia exit the cell cycle and redifferentiate to restore pe-
ripheral nerve function. PH3 immunostaining was initially used to
assess the proportion of proliferating SCs 14 d after crush, a time
when SCs have normally exited cell cycle and are actively differenti-
ating. Interestingly, PH3 immunoreactivity showed that while the
number of proliferating SCs inCtrl nerves had returned topreinjury
levels, significantly more SCs in Dicer-SCKO nerves were still ac-




Consistent with the reduced ability of miRNA-deficient SCs to exit
cell cycle in a timelymanner, nerves fromDicer-SCKOmice showed
reduced remyelination compared with nerves from Ctrl mice, as
indicated by a decrease in the total number ofmyelinated axons 14d
after injury (Fig. 3g,h). Note that this difference in remyelination
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after injury in Dicer-SCKO mice was not




 203.5 18.9; p
 0.6). An
examination of electron micrographs of in-
jured sciatic nerves from Ctrl and Dicer-
SCKO mice revealed equivalent total
numbers of regenerated axons (remyeli-
nated and non-remyelinated axons/10K
m2: Ctrl 
 525  46.2; Dicer-SCKO 

576.9 2.5; p
 0.3; Fig. 3f). Interestingly,
28 d after nerve injury, the total number of
myelinated axons in nerves from Dicer-
SCKO and Ctrl mice were similar (Fig.
3g,h), but the axons in Dicer-SCKO nerves
remained more thinly myelinated [G-ratio
(axon area/fiber area): Ctrl
 0.41 0.016;
Dicer-SCKO
 0.46 0.012; p
 0.05; Fig.
3h]. Together, these results support the the-
ory that SC miRNAs modulate the injury
response by cooperating with transcrip-
Figure 3. SCs with disrupted miRNA processing have delayed cycling between differentiation states after peripheral nerve
injury. a, YFP fluorescence in SCs (arrowheads) of longitudinal sciatic nerve sections of Rosa26-YFP/PLP-CreERTmice 8weeks after
injection with tamoxifen. PLP-CreERT induces specific and efficient recombination in most SCs and excision-dependent YFP
4
fluorescence is localized to regions of SC cytoplasm, but not to
axons (Tuj1; note non-overlapping Tuj1 and YFP staining).
Scale bar, 50m. b, qRT-PCR results show efficient depletion
of Dicer1 mRNA and of mature miRNAs in Dicer-SCKO sciatic
nerves 8 weeks after tamoxifen-induced recombination. Dicer
mRNA levels and the levels of miR-34a and miR26a in the sci-
atic nerve of Dicer-SCKO mice at this time were decreased by
60% ( p 0.001 in all three cases, two-tailed Student’s t
test) compared with Ctrl littermates. Reported values are nor-
malized to GAPDH for mRNA and U6 for miRNAs; error bars
represent SEM; n
 5 mice per genotype. c, Quantification of
the amount of myelin debris present in Ctrl and Dicer-SCKO
nerves 14 d after crush injury shows no impairment in the
ability of Tfam-deficient SCs to break down existing myelin.
Error bars represent SEM; n
 3 mice per genotype. d, e, Pic-
tures (d) and quantification (e) of PH3 immunostaining be-
tween sciatic nerves of Ctrl and Dicer-SCKO mice collected 4
(C4) or 14 (C14) days after crush injury. No difference in the
number of proliferating SCs between Ctrl and Dicer-SCKO sci-
atic nerves was observed 4 d after crush injury. At C14, how-
ever, there were significantly more PH3-positive SCs in the
sciatic nerves of Dicer-SCKO versus Ctrl mice ( p 0.05, two-
tailed Student’s t test), indicating exit from cell cycle was de-
layed in SCs with disrupted miRNA processing. Scale bar, 25
m. Error bars represent SEM; n
 3mice per genotype. f, At
C14, electronmicrographs of sciatic nerves fromCtrl andDicer-
SCKO mice show equivalent numbers of regenerated axons
(arrows, remyelinated; arrowheads, non-remyelinated). Note
the increased number of non-remyelinated axons in Dicer-
SCKO nerves. Scale bars, 2m. g, h, Pictures (h) and quanti-
fication (g) of myelinated profiles in nerves from Ctrl and
Dicer-SCKO mice before crush injury, or at C14 or C28. There is
no difference in total number of myelinated axons in nerves
fromDicer-SCKO versus Ctrlmice before crush injury. However,
examination of toluidene-blue-stained plastic sections re-
vealed a significant decrease ( p 0.05, two-tailed Student’s
t test) in the number of myelinated profiles at C14 in nerves
fromDicer-SCKOmice. By C28, therewasno longer adifference
in total number of myelinated profiles between Dicer-SCKO
and Ctrl nerves; however, nerves in Dicer-SCKO mice are more
thinlymyelinated. Scale bar, 25m. Error bars represent SEM;
n
 3 or 4 mice per genotype at each time point. *p 0.05
statistical significance.
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tional controls to ensure the correct extent and timing of SC dedif-
ferentiation, cell cycle reentry/exit, and subsequent differentiation
and remyelination after nerve injury.
miR-34a is a potential regulator of SC dedifferentiation and
proliferation after peripheral nerve injury
Cellular differentiation is tightly linked to exit from the cell cycle.
Therefore, the influence of miRNAs on cell fate decisions is often
linked to their ability to modulate cell cycle regulators (Ivey and
Srivastava, 2010). Given that SCs need to dedifferentiate and
temporarily reenter the cell cycle to support axonal regrowth
after injury (Geuna et al., 2009), we hypothesized that the regu-
lation of SC cell cycle entry/exit by miRNAs could underlie their
influence on the injury response. Among the miRNAs identified
as most likely play a role in the SC injury response (Fig. 2c), we
identified miR-34a as a particularly good candidate to regulate
the competency of SCs to proliferate or differentiate.miR-34a is a
tumor suppressor gene whose ectopic expression can induce cell
cycle arrest (Hermeking, 2010).Moreover, Notch1 and cyclin D1
(Ccnd1), two important mediators of SC dedifferentiation, pro-
liferation, and cell cycle entry/exit after peripheral nerve injury
(Kim et al., 2001;Woodhoo et al., 2009), are targets ofmiR-34a in
cancer cells (Sun et al., 2008; Pang et al., 2010). In addition, we
identified a negative target bias for miR-34a in SCs for genes in
the proliferation cluster (Fig. 2c), suggesting that miR-34a is a
modulator of cell cycle regulators in SCs.
To verify a potential role of miR-34a in the regulation of cell
cycle entry in SCs, we first examined the expression of this
miRNA in more detail. Quantitative RT-PCR confirmed that
miR-34a is highly expressed in adult peripheral nerves (Ctrl), but
that its expression level drops sharply after nerve crush (C4) or
transection (Trx14) when SCs dedifferentiate and reenter the cell
cycle. miR-34a expression, however, is restored to preinjury lev-
els as SCs exit the cell cycle and redifferentiation ensues (C7, C14;
Fig. 4a). The expression pattern of miR-34a before and after in-
jury is consistent with a role in the modulation of cell cycle reg-
ulators in SCs.
We next assessed the effect of the differential expression of
miR-34a after nerve injury on Notch1 and Ccnd1, two putative
targets relevant to SC dedifferentiation/proliferation and the in-
jury response (Atanasoski et al., 2001; Kim et al., 2001;Woodhoo
et al., 2009). We overexpressed miR-34a in HEK293T cells to-
Figure 4. miR-34a targets Notch-1 and Ccnd1 to regulate SC proliferation in vitro. a, The
dynamic regulation of miR-34a expression in sciatic nerves after crush injury suggests a poten-
tial role in themodulation of cell cycle regulators.miR-34a levels are significantly decreased 4 d
after crush injury ( p 0.01, two-tailed Student’s t test) but recover as redifferentiation ensues
(C14). After nerve transection (Trx), an injury paradigm in which remyelination does not occur,
4
mir-34a levels remain low compared with uninjured nerves even 14 d after injury (p 0.05,
two-tailed Student’s t test). Reported values are normalized to U6; error bars represent SEM;
n
 3–6mice at each time point. b, miR-34a directly interacts with the 3UTRs of Ccnd1 (top)
and Notch1 (bottom). Overexpression of miR-34a but not of Ctrl miRNA in HEK293T cells ex-
pressing a luciferase reporter construct carrying the 3UTR of either Notch1 or Ccnd1 results in
significantly decreased luciferase activity ( p 0.01 in both cases, two-tailed Student’s t test).
Error bars represent SEM; n
 3 independent assays c, qRT-PCR measurements show that the
expression pattern of Ccnd1 (top) and Notch1 (bottom) after injury is inversely correlated with
that ofmiR-34a, suggesting a direct targeting of these transcripts bymiR-34a. Reported values
arenormalized toGAPDH formRNAandU6 formiRNAs; error bars represent SEM;n
3–6mice
at each time point.d, e, Lentivirus-mediatedmir-34a overexpression (3-fold) in cultured SCs
significantly reduces Notch1 and Ccnd1mRNA (d; p 0.05, in both cases, two-tailed Student’s
t test) andprotein levels (e,2.5-fold decreas). FL, Full-length; NTM, cleaved transmembrane/
intracellular region. qRT-PCR reported values are normalized to GAPDH; error bars represent
SEM; n
 duplicatewells from three independent assays. f, Lentivirus-mediatedmir-34a over-
expression (3-fold) impairs the ability of SCs to proliferate in the presence of DRG axons.
miR-34a-expressing SCs have a significantly decreased axon-induced proliferation in vitro com-
pared with control SCs (no significant difference at day 1; p 0.01 at days 3 and 5; two-tailed
Student’s t test). Error bars represent SEM; n
 triplicate wells from two independent assays.
*p 0.05 statistical significance.
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gether with a luciferase construct containing the 3-UTRof either
Notch1 orCcnd1 and confirmed that, as previously reported (Sun
et al., 2008; Pang et al., 2010), miR-34a directly recognized and
interacted with the transcripts of these two genes (Fig. 4b). Con-
sistent with direct targeting ofNotch1 andCcnd1 bymiR-34a, the
expression pattern of these two genes was reciprocally correlated
with that of miR-34a following axonal degeneration (i.e., miR-
34a expression decreased after injury as Notch1 and Ccnd1 ex-
pression increased). The converse expression pattern was
observed as SC redifferentiation took place (Fig. 4c). Further-
more, when miR-34a was overexpressed in isolated SCs, Ccnd1
and Notch1 were downregulated at both the transcript and pro-
tein levels (Fig. 4d,e). In SCs, therefore, miR-34a directly targets
at least two positive regulators of SC dedifferentiation and prolifer-
ation (Notch1 and Ccnd1). In addition to Notch1 and Cnd1, other
potentially relevant targets to SC dedifferentiation and remyelina-
tion (e.g., YY1) could alsomediate someof the effects ofmiR-34aon
the injury response (He et al., 2010; Chen et al., 2011).
Finally, to directly determine whether miR-34a regulates cell
cycle entry and exit in SCs, we assessed the effect of overexpress-
ing thismiRNAon the axon-induced proliferation of SCs in vitro.
When isolated SCs are cultured in the presence of DRG neurons,
contact with axons initially induces SCs to enter the cell cycle and
proliferate.We found that ectopic expression of miR-34a did not
affect SC health and viability, but severely inhibited DRG axon-
induced proliferation of SCs in vitro (Fig. 4f). Together, our re-
sults indicate that mir-34 can directly interact with positive
regulators of dedifferentiation and proliferation in SCs to control
cell cycle dynamics in these peripheral glial cells, thus providing a
mechanism by which miRNAs could modulate proper cycling of
SCs between the distinct differentiation states that support nerve
regeneration after injury.
miR-140 targets Egr2, a master regulator of myelination, to
help modulate SC redifferentiation after nerve injury
The differentiation status of SCs after injury is determined by the
balance between signaling systems that drive SCmaturation/my-
elination versus those that induce SC dedifferentiation/prolifer-
ation (Jessen and Mirsky, 2008). While we initially found that
most SCmiRNAs interact with targets involved in SC dedifferen-
tiation/proliferation (see above), we also searched for miRNAs
that targeted positive regulators of myelination. To this end, we
focused on identifying miRNAs that interact with Egr2, a tran-
scription factor that is required for the formation and mainte-
nance of myelin and is often mutated in patients with peripheral
myelinopathies (Svaren and Meijer, 2008).
In silico analysis using PicTar (Krek et al., 2005), TargetScanS
(Grimson et al., 2007), and miRanda (John et al., 2004) algo-
rithms identified a putative binding site for miR-140 in the 3-
UTR of Egr2 (Fig. 5a). This binding site has an exact match to the
2–8 bp seed sequence of mousemiR-140 (AGUGGUU), which is
highly conserved in human, rat, dog, and horse; thus, thismiRNA
was selected for further testing. Although ourmicroarray analysis
detected expression of miR-140* (which originates from the op-
posite arm of the pre-miRNA for mir-140) rather than miR-140
in nerve samples (Fig. 1), qRT-PCR confirmed that miR-140 is
also expressed in adult peripheral nerve.Moreover, we found that
miR-140 expression was dynamically regulated after peripheral
nerve injury, i.e., its expression level was significantly decreased
immediately after nerve crush (C4) and remained low until at
least C7 (Fig. 5b). miR-140 expression was restored to preinjury
levels once SC redifferentiation ensued (C14; Fig. 5b). Interest-
ingly, the identified expression pattern of miR-140 after periph-
eral nerve injury is positively correlated with that of its putative
target Egr2 (Fig. 5c), suggesting that miR-140 influences the in-
jury response by fine-tuning the steady-state level of Egr2 in SCs
that are actively forming or maintaining myelin (Tsang et al.,
2007).
The dynamic regulation of miR-140 during active myelin re-
modeling prompted us to further examine thismiRNA in SCs. To
confirm that Egr2 is a target of miR-140, we first cotransfected
HEK293T cells with plasmids encoding either pre-mir-140 or a
control pre-miRNA, together with a luciferase reporter construct
carrying the 3UTR of Egr2. Coexpression of this reporter plas-
mid with miR-140 decreased luciferase activity in these cells, in-
dicating thatmiR-140 can directly recognize and interactwith the
Egr2 3UTR (Fig. 5d). This interaction was dependent on the
computationally predictedmiR-140 binding site in this region, as
a 3UTR fragment containing a mutant site was no longer re-
sponsive to coexpression of pre-mir-140 (Fig. 5d). Consistent
with results from these luciferase reporter assays, Egr2 protein
levels were reduced 2.8-fold in cultured SCs overexpressingmiR-
140 (Fig. 5e). These results identify Egr2 as a new target of miR-
140 and indicate that this miRNA directly interacts with Egr2 via
a highly conserved site in its 3UTR to regulate the expression of
this transcription factor in SCs.
Finally, we examined whether miR-140 affected the ability of
SCs to differentiate andmyelinate in vitro. In the absence of neu-
rons, prolonged exposure to cAMP-stimulating agents can pro-
mote SC growth arrest and differentiation and induce expression
of genes typically associated with myelinating SCs (e.g., Mpz and
Pmp22) (Jessen et al., 1991;Monje et al., 2009).Using this system,
we evaluated the effect of miR-140 overexpression on SC differ-
entiation. Consistent with the downregulation of Egr2 protein by
mir-140 in SCs (Fig. 5e), cAMP-induced, Egr2-mediated upregu-
lation of myelin markers in cultured SCs was inhibited in the
presence of this miRNA (cAMP-induced gene expression fold
induction,MPZ: Ctrl miR
 4.7 0.51; miR-140
 2.09 0.35;
p 0.05; PMP22: Ctrl miR
 1.5 0.06; miR-140
 0.9 0.06;
p 0.05).
When SCs are cultured together with DRGs in the presence of
ascorbic acid, DRG axons will support the differentiation of SCs
and the formation ofmyelin (Wood et al., 1990).Myelination can
be monitored in this system by using MBP immunostaining as a
marker. We found that overexpression of miR-140 in SCs cocul-
tured with DRGs inhibited the expression of Egr2 as well as a
number of myelination markers (Fig. 5f). Most importantly,
miR-140 overexpression inhibited myelination in this in vitro
assay, as evidenced by the decreased number of myelin segments
detected byMBP immunostaining (Fig. 5g). Together, our results
indicate that miR-140 can directly interact with Egr2 and modu-
late the level of this transcription factor to regulate myelination.
This suggests another mechanism by which miRNAs may mod-
ulate the injury-induced regenerative process of SCs in peripheral
nerves.
Discussion
Following axonal loss, SCsmount a regenerative response involving
coordinated dedifferentiation, proliferation, and redifferentiation
that helps restore peripheral nerve function. Extensive work has es-
tablished that this SC injury response is driven by an intricate tran-
scriptional program controlling the balance between positive and
negative regulators of SC differentiation (Jessen andMirsky, 2008).
The present study describes a new regulatory layer of the SC injury
response involving posttranscriptional regulation by miRNAs. We
show that SC miRNAs modulate the injury response by targeting
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primarily positive regulators of SC dediffer-
entiation/proliferation, cooperating with
transcriptional controls to ensure rapid and
robust transitions between the distinct dif-
ferentiation states that support nerve regen-
eration.Moreover,wealso identifymiR-34a
andmiR-140 as important functional regu-
lators of SC proliferation and myelination,
two central processes of the SC regenerative
response after injury.miRNAs therefore ap-
pear to be important modulators of the SC
regenerative response after peripheral nerve
injury.
miRNAs are thought to have evolved
to canalize the genetic network and confer
robustness to gene expression programs
(Hornstein and Shomron, 2006). miR-
NAs achieve this by integrating into the
preexisting genetic network in two ways.
On the one hand, miRNAs can wire into
coherent feedforward loops (FFLs) such
that high expression of a given miRNA is
induced at a time or location when the
transcription of its predicted targets is re-
pressed (negative target bias) (Hornstein
and Shomron, 2006; Tsang et al., 2007).
This type of network motif functions as a
posttranscriptional failsafe and results in
mutually exclusive expression domains
for the miRNA and its putative targets
(Mansfield et al., 2004; Stark et al., 2005).
Figure 5. miR-140 directly interacts with Egr2 to regulate SC myelination in vitro. a, PicTar, TargetScanS, and miRanda algo-
rithms all identify a putative binding site for miR-140 in the 3-UTR of Egr2. b, qRT-PCR results show that miR-140 is expressed in
4
mouse sciatic nerves and that its expression is dynamically
regulated after injury. miR-140 expression is significantly de-
creased after injury (C4 and C7, p 0.05, two-tailed Student’s
t test) but recovers as redifferentiation ensues (C14, no signif-
icant difference). Reported values are normalized to U6; error
bars represent SEM; n
 3–6mice at each time point. c, qRT-
PCRmeasurements show that the expression pattern of Egr2 is
correlated with that of miR-140. Reported values are normal-
ized to GAPDH for mRNA and U6 for miRNAs; error bars repre-
sent SEM; n 
 3–6 mice at each time point. d, Luciferase
assays confirm a direct interaction between miR-140 and the
3-UTR of Egr2. Overexpression of miR-140, but not of Ctrl
miRNA, in HEK293T cells expressing a luciferase reporter con-
struct carrying the 3-UTR of Egr2 results in significantly de-
creased luciferase activity ( p 0.05, two-tailed Student’s t
test). Mutating the predicted landing pad for miR-140 in the
3-UTR of Egr2 disrupts the interaction betweenmiR-140 and
the Egr2 3-UTR luciferase construct and restores luciferase
activity. e,Western blot analysis shows that overexpression of
miR-140 in cultured SCs reduces the levels of Egr2 protein
2.8-fold. f, Overexpression of miR-140 in SCs significantly
decreases the levels of Egr2 as well as of a number of myelin
markers when these cells are cocultured with DRGs and in-
duced tomyelinate (in all casesp0.05, two-tailed Student’s
t test). Reported values are normalized to GAPDH; error bars
represent SEM; n 
 duplicate wells from two independent
assays. g, Similarly, miR-140 overexpression significantly in-
hibits the ability of SCs to form myelin in vitro in cocultures
withDRGneurons as visualized byMBP immunostaining ( p
0.05, two-tailed Student’s t test). Error bars represent SEM;
n
 triplicatewells fromthree independent assays. *p0.05
statistical significance.
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On the other hand, miRNAs can wire into incoherent FFLs,
which would promote high expression of a given miRNA at a
time or locationwhere its predicted targets are also abundant (pos-
itive target bias) (Hornstein and Shomron, 2006; Tsang et al., 2007).
Biological examples of incoherent FFLs (Karres et al., 2007) have
shown that in this type of networkmotifmiRNAshave a fine-tuning
action and keep protein levels in the correct functional range. Our
work demonstrates that SC miRNAs show a prevalence of negative
target biases during the SC injury response. This indicates that SC
miRNAs primarily participate in coherent FFLs. Moreover, the ex-
pression of most SC miRNAs after injury was negatively correlated
with that of positive regulator of SC dedifferentiation/proliferation.
Interestingly, we also found that predicted targets of SCmiRNAs are
enriched for genes active in immature or proliferating SCs that are
quiescent in adult, differentiated SCs. Together, these observations
indicate that SC miRNAs regulate the injury response primarily by
inhibiting positive regulators of SC dedifferentiation/proliferation
and thereby reinforcing a preexisting transcriptional silencing
mechanism that keeps dedifferentiation/proliferation-related genes
quiescent in differentiated SCs yet allows their induction following
axonal degeneration.
The above results imply that the majority of miRNAs ex-
pressed in mature SCs are involved in maintaining the differen-
tiated state. In accordance with this, we found that immediately
after injury, most SC miRNAs are downregulated, which allows
for the transcriptionally driven dedifferentiation of SCs. We also
observed that, similar to what has been reported for SC postnatal
development (Bremer et al., 2010; Pereira et al., 2010; Yun et al.,
2010), the expression of most SC miRNAs is upregulated once
again shortly after axonal regrowth. Because most SC miRNAs
target positive regulators of SC dedifferentiation/proliferation
that must be repressed for proper SC differentiation to occur (Le
et al., 2005), this serves to facilitate redifferentiation and stabili-
zation of themature SCphenotype. This observation is consistent
with studies showing that miRNAs are generally expressed at
lower levels in immature or dedifferentiated tissues than in dif-
ferentiated ones (Lu et al., 2005;Wienholds et al., 2005) and with
the idea that miRNAs are largely involved in promoting, induc-
ing, and stabilizing differentiated phenotypes (Wienholds and
Plasterk, 2005). It is possible that manipulation of SC miRNAs
could be used therapeutically to facilitate SC differentiation after
injury or reverse the effects of neuropathy.
The therapeutic modulation of SC miRNAs, however, re-
quires the identification of specific miRNAs playing critical roles
in the establishment and maintenance of SC differentiation as
well as in the modulation of the SC injury response. We identify
miR-34a as one such candidate. We found that miR-34 was able
to critically regulate SC cell cycle exit by directly interacting with
Ccnd1 transcripts and impinging on Notch signaling, a central
modulator of SC dedifferentiation after injury (Woodhoo et al.,
2009). OthermiRNAs are likely to play similar roles; for example,
let-7 family members enhance differentiation and inhibit stem
cell self-renewance (Melton et al., 2010).Moreover, this family of
miRNAs participates in regenerative processes in zebrafish (Ra-
machandran et al., 2010). Intriguingly, our microarray analysis
found that several members of the let-7 family were differentially
regulated in SCs after peripheral nerve injury.
While our work shows that most SC miRNAs interact with
targets involved in SC dedifferentiation/proliferation, we also
identified miR-140 as a potential regulator of Egr2. Egr2 is an
essential transcription factor formyelinogenesis and is oftenmu-
tated in patients with peripheral myelinopathy (Svaren andMei-
jer, 2008). Accordingly, we found that overexpression ofmiR-140
in SCs impaired their ability to formmyelin in vitro. Interestingly,
the expression pattern of miR-140 and Egr2 indicates the pres-
ence of an incoherent FFL (Hornstein and Shomron, 2006; Tsang
et al., 2007) in which both transcript andmiRNA are coexpressed
at the same time in SCs. This suggests that miR-140 may act to
maintain Egr2 expression within precise functional levels. This is
particularly interesting because myelin formation and mainte-
nance is very sensitive to gene dosage effects. In fact, both abnor-
mally low and high levels of specific myelin proteins can cause
peripheral neuropathy in humans (Meyer zu Ho¨rste et al., 2006).
Regulation of expression thresholds could therefore be a second
mechanism, together with reinforcement of transcriptional si-
lencing, by which SC miRNAs modulate the injury response of
these glia and promote regeneration of peripheral nerves.
In summary, throughmiRNA expression profiling after nerve
damage and examination of the effects of impaired miRNA pro-
cessing on the SC injury response, the present study establishes a
critical role formiRNAs in themodulation of the SC regenerative
response in peripheral nerves. We demonstrate that SC miRNAs
ensure rapid and robust transitions between the distinct differ-
entiation states necessary to support nerve regeneration by rein-
forcing the transcriptional silencing of dedifferentiation- and
proliferation-related genes. Modulation of SC miRNAs could
therefore offer a new therapeutic avenue to enhance nerve regen-
eration and improve the treatment of neurodegenerative diseases
characterized by axonopathy.
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